Marketing-authorisation holder · Serbia
Roche Doo Beograd
57 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Serbia
57 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 57
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Actemra®80mg/4mL · koncentrat za rastvor za infuziju | Tocilizumab | Serbia | Authorised | 2025 |
| Actemra®200mg/10mL · koncentrat za rastvor za infuziju | Tocilizumab | Serbia | Authorised | 2025 |
| Actemra®162mg · rastvor za injekciju u napunjenom injekcionom špricu | Tocilizumab | Serbia | Authorised | 2025 |
| Actemra®400mg/20mL · koncentrat za rastvor za infuziju | Tocilizumab | Serbia | Authorised | 2025 |
| Alecensa®150mg · kapsula, tvrda | Alectinib | Serbia | Authorised | 2023 |
| Alecensa®150mg · kapsula, tvrda | Alectinib | Serbia | Authorised | 2023 |
| Avastin®100mg/4mL · koncentrat za rastvor za infuziju | Bevacizumab | Serbia | Authorised | 2021 |
| Avastin®100mg/4mL · koncentrat za rastvor za infuziju | Bevacizumab | Serbia | Authorised | 2021 |
| Avastin®400mg/16mL · koncentrat za rastvor za infuziju | Bevacizumab | Serbia | Authorised | 2021 |
| Avastin®400mg/16mL · koncentrat za rastvor za infuziju | Bevacizumab | Serbia | Authorised | 2021 |
| Cellcept®500mg · film tableta | Mycophenolate mofetil | Serbia | Authorised | 2023 |
| Cellcept®250mg · kapsula, tvrda | Mycophenolate mofetil | Serbia | Authorised | 2023 |
| Cellcept®500mg · film tableta | Mycophenolate mofetil | Serbia | Authorised | 2023 |
| Columvi®2.5mg · koncentrat za rastvor za infuziju | Glofitamab | Serbia | Authorised | 2026 |
| Columvi®10mg · koncentrat za rastvor za infuziju | Glofitamab | Serbia | Authorised | 2026 |
| Cotellic®20mg · film tableta | Cobimetinib | Serbia | Authorised | 2021 |
| Enspryng®120mg/mL · rastvor za injekciju u napunjenom injekcionom špricu | Satralizumab | Serbia | Authorised | 2022 |
| Erivedge®150mg · kapsula, tvrda | Vismodegib | Serbia | Authorised | 2023 |
| ESBRIET®267mg · film tableta | Pirfenidone | Serbia | Authorised | 2024 |
| ESBRIET®801mg · film tableta | Pirfenidone | Serbia | Authorised | 2024 |
| Evrysdi®0.75mg/mL · prašak za oralni rastvor | Risdiplam | Serbia | Authorised | 2022 |
| Gazyva®1000mg · koncentrat za rastvor za infuziju | Obinutuzumab | Serbia | Authorised | 2026 |
| Hemlibra®150mg/mL · rastvor za injekciju | Emicizumab | Serbia | Authorised | 2024 |
| Hemlibra®150mg/mL · rastvor za injekciju | Emicizumab | Serbia | Authorised | 2024 |
| Hemlibra®150mg/mL · rastvor za injekciju | Emicizumab | Serbia | Authorised | 2024 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Serbia | 57 | 51 | 6 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.